Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck’s Allergopharma opens €42m biopharmaceutical plant

March 7, 2017
Manufacturing and Production Allergopharma, Merck

Allergopharma, a subsidiary of Germany’s Merck, has completed construction on its new €42 million biopharmaceutical facility and declared it open …

News
bernie_2

Vermont senators call for restraints on “beautiful” pharma advertising

March 6, 2017
Manufacturing and Production, Sales and Marketing Bernie Sanders, Vermont, pricing

Bernie Sanders is yet again leading the charge against US pharma as Vermont senators have rallied against advertising and marketing …

News
sink

FDA approves first treatment for excessive night-time urination

March 6, 2017
Manufacturing and Production FDA, Noctiva, Serenity

The FDA has approved Noctiva, administered as a nasal spray, for the treatment of people suffering from nocturnal polyuria – …

News
europe_tied_in_knots

Negotiating the EU pricing system: How the financial crisis has encouraged closer-knit cooperation between member states

March 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, pricing

Drug pricing is a topic that has become headline-friendly over the past year. It has come to dominate media coverage …

Feature

Lilly posts impressive psoriasis results in comparison study

March 6, 2017
Research and Development, Sales and Marketing J&J, JJ, Stelara, Taltz, lilly

Eli Lilly has revealed strong results in a study comparing its psoriasis treatment, Taltz (ixekizumab), to Johnson & Johnson’s Stelara. …

News
mediaphoto7_large

Cipla halts HIV drug production due to delayed government funding

March 6, 2017
Sales and Marketing Cipla, HIV, India, Lopinavir

Indian pharmaceutical company Cipla has halted production of its child-friendly antiretroviral HIV treatment Lopinavir (ABT-378) due to the failure by …

News
abbvie_0

UK High Court rules against AbbVie’s Humira patents

March 6, 2017
Sales and Marketing AbbVie, Biogen, Fujifilm Kyowa Kirin Biologics, Humira, Samsung Bioepis, biosimilar

The UK High Court has ruled that two of AbbVie patents, related to dosing regimens for rheumatoid arthritis, psoriasis and …

News
janssen_latest_logo_on_sign_closer

Phase 3 data for Janssen psoriasis drug shows efficacy over Humira

March 6, 2017
Research and Development, Sales and Marketing Humira, Janssen, guselkumab, psoriasis

Janssen has revealed new Phase 3 data for its human monoclonal antibody guselkumab in the treatment of adults with moderate …

News
otsuka_holdings_logo

Otsuka to acquire Neurovance in potential $250 million deal

March 6, 2017
Sales and Marketing ADHD, Neurovance, Otsuka Pharmaceuticals

Otsuka Pharmaceuticals, a pharmaceutical firm with headquarters in Japan, has agreed to pay a potential $250 million in a deal …

News

Bioverativ adds new member to board of directors

March 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Biogen spinout, Bioverativ, have moved to consolidate its board of directors by appointing Anna Protopapas to the board. Protopapas becomes …

Appointment
genes

Gene therapy: Advanced treatments for a new era

March 3, 2017
Medical Communications gene therapy

Aranca discusses the considerable advances that have occured in the last few years in gene therapy.Considerable research has been conducted …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s been a busy week on Pharmafile.com over the last seven days. Europe’s first biosimilar treatment for cancer continues to …

News
eu_and_fda

EU-US reach landmark deal on mutual recognition of manufacturing inspection

March 3, 2017
Medical Communications EMA, EU, FDA, US

The European Union and the US has announced that an agreement has been made to mutually recognise inspection of drug …

News

Price cuts bring 14 Cancer Drugs Fund treatments into routine NHS use

March 3, 2017
Medical Communications, Sales and Marketing CDF, NICE

NICE has revealed that it has reached the halfway point in its review of the old Cancer Drugs Fund (CDF) …

News
cma_logo

CMA accuses Concordia and Actavis of illegal agreement to maintain high prices

March 3, 2017
Medical Communications, Sales and Marketing Actavis UK, CMA, Concordia, competition and markets authority

The Competition and Markets Authority (CMA) has alleged that Concordia and Actavis UK entered into a clandestine agreement to maintain …

News

Ipsen appoints new Executive Vice President

March 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ipsen

Ipsen has announced the appointment of Benoit Hennion as Executive Vice President and President of Primary Care. Hennion has worked …

Appointment
juno

Juno Therapeutics abandons problem leukaemia drug

March 2, 2017

Juno Therapeutics has finally called time on the development of its CAR-T therapy, JCAR015, after one of the most turbulent …

News
shutterstock_128521253

Are we prepared for the ‘real world’?

March 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing opinion, real world data, recruitment

Dr Dilruwan Chaminda Herath, Medical Director for Chiesi Group, discusses whether the lack of impetus to push for recruitment of …

Feature

NICE approves first biliary cholangitis drug in 20 years

March 2, 2017
Sales and Marketing Intercept Pharmaceuticals, intercept, liver disease, ocaliva, primary biliary cholangitis

Intercept Pharmaceuticals has announced that Ocaliva (obeticholic acid) has been approved by the National Institute for Health and Care Excellence …

News
x-ray-1704854_960_720

Osteoporosis drugs potentially causing long-term bone weakness

March 2, 2017
Research and Development osteoporosis

Medication that is used to treat those suffering from weakened bones may actually be causing further damage, new research from …

News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026